VERU INC. Finance Lease, Liability, Undiscounted Excess Amount
VERU INC. (VERU) had Finance Lease, Liability, Undiscounted Excess Amount of $403 as of 2021-09-30, per its 10-K filed 2021-12-02.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2021-12-02
- 2021-09-30: Finance Lease, Liability, Undiscounted Excess Amount $403.00.
- 2020-09-30: Finance Lease, Liability, Undiscounted Excess Amount $3.17K.
- 2020-06-30: Finance Lease, Liability, Undiscounted Excess Amount $4.26K.
- 2020-03-31: Finance Lease, Liability, Undiscounted Excess Amount $5.50K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2021-09-30 | $403.00 10-K · filed 2021-12-02 |
| 2020-09-30 | $3.17K 10-K · filed 2020-12-10 |
| 2020-06-30 | $4.26K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $5.50K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $6.88K 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |